Top

Published in:

01-07-2018 | Gynecologic Oncology

Lymphatic Spread of Ovarian Cancer: Can the Anatomical and Pathological Knowledge Help a Personalized Treatment?

Author: Giovanni D. Aletti, MD

Published in: Annals of Surgical Oncology | Issue 7/2018

Excerpt

Epithelial ovarian cancer has been recently classified into several different entities, according to the different pathogenesis. The traditional grading system of different histologic subtypes, which led to the concept of having different grade of the same tumor, has been changed over the past decades. A new system identifies different types with different prognosis and clinical behavior.1 Six main histologic subtypes were identified:

High-grade serous carcinoma

Low-grade serous carcinoma

Endometrioid carcinoma (which maintains a grading system)

Mucinous carcinoma (which maintains a grading system)

Clear cell carcinoma

Mixed/undifferentiated carcinoma

…

Shih Ie M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164(5):1511–8.CrossRefPubMed

Prat J, FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1–5.CrossRefPubMed

Heitz F, Harter P, Ataseven B, Heikaus S, Schneider S, et al. Stage and histologic subtype dependent frequency of lymph node metastases in patients with epithelial ovarian cancer undergoing systematic pelvic and para-aortic lymphadenectomy. Ann Surg Oncol. 2018; https://doi.org/10.1245/s10434-018-6412-y.PubMedCrossRef

Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, et al. LION: Lymphadenectomy in ovarian neoplasms—a prospective randomized AGO study group led gynecologic cancer intergroup trial. Resulted reported at ASCO Meeting, Chicago, IL; 2017.

Maggioni A, Benedetti Panici P, Dell’Anna T, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;18:95(6):699–704.CrossRef

Kleppe M, Wang T, Van Gorp T, Slangen BF, Kruse AJ, Kruitwagen RF. Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol. 2011;123(3):610–4.CrossRefPubMed

Minig L, Heitz F, Cibula D, Bakkum-Gamez JN, Germanova A, Dowdy SC, et al. Patterns of lymph node metastases in apparent stage i low-grade epithelial ovarian cancer: a multicenter study. Ann Surg Oncol. 2017; 24(9):2720–6.CrossRefPubMed

Title: Lymphatic Spread of Ovarian Cancer: Can the Anatomical and Pathological Knowledge Help a Personalized Treatment?
Author: Giovanni D. Aletti, MD
Publication date: 01-07-2018
Publisher: Springer International Publishing
Published in: Annals of Surgical Oncology / Issue 7/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-018-6475-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Lymphatic Spread of Ovarian Cancer: Can the Anatomical and Pathological Knowledge Help a Personalized Treatment?

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2018

Health Disparities Impact Expected Treatment of Pancreatic Ductal Adenocarcinoma Nationally

Will Palliative Care Ever Be Cool?

Surgical Risk Factors for the Delayed Initiation of Adjuvant Chemotherapy in Breast Cancer

Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival

What is the Incidence of Malignancy in Resected IPMN? An Analysis of Over 100 U.S. Institutions in a Single Year

Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer